Published in Nat Rev Cancer on July 02, 2015
Metastatic colonization by circulating tumour cells. Nature (2016) 1.31
Identification of neutral tumor evolution across cancer types. Nat Genet (2016) 1.25
The mathematics of cancer: integrating quantitative models. Nat Rev Cancer (2015) 1.00
A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds. Cell (2016) 0.96
Distinctive properties of metastasis-initiating cells. Genes Dev (2016) 0.91
Surviving at a distance: organ specific metastasis. Trends Cancer (2015) 0.90
The mini-driver model of polygenic cancer evolution. Nat Rev Cancer (2015) 0.87
Interrogating open issues in cancer precision medicine with patient-derived xenografts. Nat Rev Cancer (2017) 0.87
Tumour Cell Heterogeneity. F1000Res (2016) 0.83
ImmunoPET to help stratify patients for targeted therapies and to improve drug development. Eur J Nucl Med Mol Imaging (2016) 0.82
Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolism. JCI Insight (2016) 0.77
Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity. Cold Spring Harb Perspect Med (2016) 0.77
Defining Clonal Color in Fluorescent Multi-Clonal Tracking. Sci Rep (2016) 0.77
Patient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic review. Oncotarget (2016) 0.77
Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapy. Cancer Sci (2016) 0.77
Quantification of HER2 heterogeneity in breast cancer-implications for identification of sub-dominant clones for personalised treatment. Sci Rep (2016) 0.77
Echoes of the embryo: using the developmental biology toolkit to study cancer. Dis Model Mech (2016) 0.76
Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas. Oncotarget (2016) 0.76
A step-by-step microRNA guide to cancer development and metastasis. Cell Oncol (Dordr) (2017) 0.75
Understanding cancer complexome using networks, spectral graph theory and multilayer framework. Sci Rep (2017) 0.75
Harbouring public good mutants within a pathogen population can increase both fitness and virulence. Elife (2016) 0.75
Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization. Oncotarget (2017) 0.75
Understanding cell signaling in cancer stem cells for targeted therapy - can phosphoproteomics help to reveal the secrets? Cell Commun Signal (2017) 0.75
A single dividing cell population with imbalanced fate drives oesophageal tumour growth. Nat Cell Biol (2016) 0.75
An Assessment of the Potential Use of BNNTs for Boron Neutron Capture Therapy. Nanomaterials (Basel) (2017) 0.75
Clonal evolution of acute myeloid leukemia highlighted by latest genome sequencing studies. Oncotarget (2016) 0.75
Drug Development Against Metastatic Cancers. Yale J Biol Med (2017) 0.75
Pointwise mutual information quantifies intratumor heterogeneity in tissue sections labeled with multiple fluorescent biomarkers. J Pathol Inform (2016) 0.75
Measuring intratumor heterogeneity by network entropy using RNA-seq data. Sci Rep (2016) 0.75
Clonal cooperativity in heterogenous cancers. Semin Cell Dev Biol (2016) 0.75
Elucidation of molecular and functional heterogeneity through differential expression network analyses of discrete tumor subsets. Sci Rep (2016) 0.75
Germline Proliferation Is Regulated by Somatic Endocytic Genes via JNK and BMP Signaling in Drosophila. Genetics (2017) 0.75
Contextual organismality: Beyond pattern to process in the emergence of organisms. Evolution (2016) 0.75
Cooperation among heterogeneous prostate cancer cells in the bone metastatic niche. Oncogene (2016) 0.75
Metabolic origins of spatial organization in the tumor microenvironment. Proc Natl Acad Sci U S A (2017) 0.75
Patient-derived tumour xenografts for breast cancer drug discovery. Endocr Relat Cancer (2016) 0.75
Means to the ends: The role of telomeres and telomere processing machinery in metastasis. Biochim Biophys Acta (2016) 0.75
Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance. Med Res Rev (2016) 0.75
Circulating Tumor Cells: Moving Biological Insights into Detection. Theranostics (2017) 0.75
Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression. Semin Cancer Biol (2017) 0.75
Feedback amplification loop drives malignant growth in epithelial tissues. Proc Natl Acad Sci U S A (2017) 0.75
Biologically Relevant Heterogeneity: Metrics and Practical Insights. SLAS Discov (2017) 0.75
Extinction rates in tumour public goods games. J R Soc Interface (2017) 0.75
mRNA expression profiles of colorectal liver metastases as a novel biomarker for early recurrence after partial hepatectomy. Mol Oncol (2016) 0.75
Analysis of risk factors for post-operative complications and prognostic predictors of disease recurrence following definitive treatment of patients with esophageal cancer from two medical centers in Northwest China. Exp Ther Med (2017) 0.75
histoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data. Nat Methods (2017) 0.75
Harnessing protein kinase A activation to induce mesenchymal-epithelial programs to eliminate chemoresistant, tumor-initiating breast cancer cells. Transl Cancer Res (2016) 0.75